Efficacy and safety of direct oral anticoagulant in morbidly obese patients with atrial fibrillation: systematic review and meta-analysis
S Thangjui, J Kewcharoen, R Yodsuwan… - European Heart …, 2022 - academic.oup.com
Aims We conducted a systematic review and meta-analysis on three outcomes. We
assessed the efficacy and safety of direct oral anticoagulants (DOAC) compared to vitamin K …
assessed the efficacy and safety of direct oral anticoagulants (DOAC) compared to vitamin K …
Meta-analysis comparing direct oral anticoagulants versus warfarin in morbidly obese patients with atrial fibrillation
K Kido, M Shimizu, T Shiga, M Hashiguchi - The American journal of …, 2020 - Elsevier
Highlights•Direct oral anticoagulants did not increase stroke or systemic embolism event
rate.•Direct oral anticoagulants had lower major bleeding rate than warfarin.•Direct oral …
rate.•Direct oral anticoagulants had lower major bleeding rate than warfarin.•Direct oral …
Safety and efficacy of direct oral anticoagulants in comparison to warfarin in obese patients with atrial fibrillation: A systematic review and meta‐analysis
A Adelkhanova, PR Oli, DB Shrestha… - Health Science …, 2024 - Wiley Online Library
Abstract Background and Aim Obesity affects nearly 650 million adults worldwide, and the
prevalence is steadily rising. This condition has significant adverse effects on cardiovascular …
prevalence is steadily rising. This condition has significant adverse effects on cardiovascular …
[HTML][HTML] Effectiveness of direct oral anticoagulants in obese adults with atrial fibrillation: a systematic review of systematic reviews and meta-analysis
Background: Atrial Fibrillation (AF) is the most common sustained cardiac arrhythmia.
Obesity is an independent risk factor for AF. Anticoagulants have been strongly …
Obesity is an independent risk factor for AF. Anticoagulants have been strongly …
Direct oral anticoagulants versus warfarin in morbidly obese patients with nonvalvular atrial fibrillation: a systematic review and meta-analysis
Background: Direct oral anticoagulants (DOACs) have been increasingly preferred over
warfarin; however, The International Society of Thrombosis and Hemostasis recommended …
warfarin; however, The International Society of Thrombosis and Hemostasis recommended …
Direct-acting oral anticoagulant choice for stroke prevention in obese patients with atrial fibrillation
T Brar, D Chua - Canadian Journal of Cardiology, 2021 - Elsevier
Anticoagulation with direct-acting oral anticoagulants (DOACs) is recommended over
warfarin for stroke prevention in patients with atrial fibrillation (AF). The efficacy of DOACs …
warfarin for stroke prevention in patients with atrial fibrillation (AF). The efficacy of DOACs …
Efficacy and safety of direct oral anticoagulants versus warfarin in patients with atrial fibrillation across BMI categories: a systematic review and meta-analysis
Objectives Concerns have arisen recently over the relationship between body mass index
(BMI) and outcomes in atrial fibrillation (AF) patients with direct oral anticoagulants (DOACs) …
(BMI) and outcomes in atrial fibrillation (AF) patients with direct oral anticoagulants (DOACs) …
Effectiveness and safety of direct oral anticoagulants for stroke prevention in atrial fibrillation patients with extreme obesity
B Elad, N Maman, S Ayalon, LH Goldstein - The American Journal of …, 2023 - Elsevier
Direct oral anticoagulants (DOACs) are a favored treatment to prevent stroke in patients with
atrial fibrillation (AF). There are limited data concerning the efficacy and safety of DOACs in …
atrial fibrillation (AF). There are limited data concerning the efficacy and safety of DOACs in …
Clinical performance of nonvitamin K antagonist oral anticoagulants in real-world obese patients with atrial fibrillation
V Russo, R Bottino, A Rago, AA Papa… - … in Thrombosis and …, 2020 - thieme-connect.com
The prevalence of both atrial fibrillation (AF) and obesity has steadily increased. Nonvitamin
K antagonist oral anticoagulants (NOACs) have been shown to be more effective and safer …
K antagonist oral anticoagulants (NOACs) have been shown to be more effective and safer …
Comparative effectiveness and safety of direct oral anticoagulants in obese patients with atrial fibrillation
Background Unlike warfarin direct oral anticoagulants (DOACs) are administered in fixed
doses, which raises concerns of its effectiveness on larger patients. Data from randomized …
doses, which raises concerns of its effectiveness on larger patients. Data from randomized …
相关搜索
- obese patients atrial fibrillation
- meta analysis atrial fibrillation
- meta analysis efficacy and safety
- efficacy and safety atrial fibrillation
- efficacy and safety oral anticoagulants
- meta analysis oral anticoagulants
- efficacy and safety warfarin in patients
- meta analysis warfarin in patients
- fibrillation patients effectiveness and safety
- meta analysis obese adults
- fibrillation patients stroke prevention
- impact of weight oral anticoagulants
- efficacy and safety impact of weight
- meta analysis impact of weight
- obese patients clinical performance
- efficacy and safety bmi categories